Kozick Linda 4

What Happened Linda Kozick, a member of RAPT Therapeutics' board of directors, was granted 4,956 restricted stock units (RSUs) on January 30, 2026. The RSUs were issued at $0.00 per unit (total $0 at grant) as an award under the company's non-employee director compensation policy. These RSUs are a form of compensation, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-01-30; Grant/award (code A) of 4,956 RSUs at $0.00 per unit.
• Filing date / accession: Form 4 filed 2026-02-02 (within a few days of the grant per the filing).
• Shares owned after transaction: Not specified in the filing.
• Footnote: RSUs are annual non-employee director awards that fully vest on the first anniversary of the grant; each RSU converts to one share of common stock upon vesting.
• No sale, purchase, exercise, or tax-withholding reported in this filing.

Context RSU grants to non-employee directors are routine compensation for board service. These RSUs will only convert into actual shares if/when they vest (one year after the grant), at which point they are typically taxable as compensation. Because this was an award rather than a market transaction, it should not be interpreted as a direct buying or selling signal by the insider.